The role of androgens in the aetiology and pathology of pre-eclampsia

Journal of Obstetrics and Gynaecology

Volumn 23, Issue 2, 2003, Pages 134-137

  Ficicioglu C ^a,b   Kutlu, T ^a  

^a Zeynep Kamil Maternity Hospital   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTRIOL; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; APGAR SCORE; ARTICLE; DISEASE SEVERITY; ESTRIOL BLOOD LEVEL; EVALUATION; FEMALE; FETUS MORTALITY; FETUS WEIGHT; HIGH RISK PREGNANCY; HORMONE BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEWBORN MORBIDITY; PATHOGENESIS; PERINATAL ASPHYXIA; PREECLAMPSIA; PREMATURITY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SOLUTIO PLACENTAE; TESTOSTERONE BLOOD LEVEL;

ADULT; ANDROGENS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 0038706037     PISSN: 01443615     EISSN: None     Source Type: Journal    
DOI: 10.1080/0144361031000074637     Document Type: Article

References (22)

1. Acromite M.T., Mantzoros C.S., Leach R.E., Hurwitz J. and Dorey L.G. (1999). Androgens in preeclampsia. American Journal of Obstetrics and Gynecology, 180, 60-63.
2. 2 receptor density and aggregation responses. Circulation, 91, 2742-2747.
3. Aksu M.F. and Şen C. (1999). Preeklampsi'de Mortalite ve Morbidite. İ.Ü. Cerrahpaşa Tip Fakültesi Sürekli Tip Eǧitimi Komisyonu 15, 17-44.
4. Bachmann J., Feltmer M., Ganten U., Stock G. and Ganten G. (1991). Sexual dimorphism of blood pressure: possible role of renin angiotensin system. Journal of Steriod Biochemistry and Molecular Biology, 40, 511-515.
5. Baker P.J., Ramey E. and Ramuell P.W. (1978). Androgen mediated sex-differences of cardiovascular responses in rats. American Journal of Physiology, 235, H242-H246.
6. Belisle S., Osathanondh R. and Tulchinsky D. (1977). The effect of constant infusion of unlabelled DHEA-S on maternal plasma androgens and estrogens. Journal of Clinical Endocrinology and Metabolism, 45, 544-550.
7. Brosens I.A., Robertson W.B. and Dixon H.G. (1972). The role of the spiral arteries in the pathogenesis of preeclampsia. Obstetrics and Gynecology Annual, 1, 177-191.
8. Buster J.E., Chang R.J., Preston D.L., Elashoff R.M., Cousins L.M., Abraham G.E., Hobel C.J. and Marshall J.R. (1979). Interrelationships of circulating maternal steroid concentrations in normal third trimester pregnancies. I. C21 steriods: progesterone, 16 alpha-hydroxyprogesterone, 17 alpha-hydroxyprogesterone, 20 alpha-dihydroprogesterone, delta 5-pregnenolone, delta 5-pregnenolone sulfate, and 17-hydroxy delta-5-pregnenolone. Journal of Clinical Endocrinology and Metabolism, 48, 133-138.
9. Dejong C.L., Dekker G.A. and Sibai B.M. (1991). The renin angiotensin aldosterone system in preeclampsia: a review. Clinical Perinatology, 18, 683-711.
10. Forest M.G., Anges I.G., Tapper A.J. and Migeon C.J. (1971). Percentage binding of testosterone, androstenedione and DHEA in plasma at the time of delivery. Journal of Clinical Endocrinology and Metabolism, 32, 417-425.
11. Friedman S.A., Taylor R.N. and Roberts J.M. (1991). Pathophysiology of preeclampsia. Clinical Perinatology, 18, 661-682.
12. Higgins J.R. and Brennecke S.P. (1998). Pre-eclampsia - still a disease of theories? Current Opinion in Obstetrics and Gynecology, 10, 129-133.
13. Johnson M., Ramey E. and Ramuell P.W. (1977). Androgen mediated sensitivity in platelet aggregation. American Journal of Physiology, 232, 381-385.
14. Laivuori H., Kaaja R., Rutanen E.M., Viinikka L. and Ylikorkala O. (1998). Evidence of high circulating testosterone in women with prior preeclampsia. Journal of Clinical Endocrinology and Metabolism, 83, 344-347.
15. Loriaux D.L., Ruder H.J., Knab D.R. and Lipsett M.B. (1972). Estrone sulfate, estrone, estradiol, and estriol plasma levels in human pregnancy. Journal of Clinical Endocrinology and Metabolism, 35, 887-891.
16. MacDonald P.C. and Siiter P.K. (1965). Origin of estrogen in women pregnant with an anencephalic fetus. Journal of Clinical Investigation, 44, 465-474.
17. Pigny P., Desailloud R., Cortet-Mudelli C., Duhamel A., Deroubaix-Allard D., Racadot A. and Dewilly D. (1997). Serum alpha-inhibin levels in polycystic ovarian syndrome: relationship to the serum androstenedione level. Journal of Clinical Endocrinology and Metabolism, 82, 1939-1943.
18. Rivarola M.A., Forest M.G. and Migeon C.J. (1968). Testosterone, androstenedione and DHEA in plasma during pregnancy and at delivery: concentration and protein binding. Journal of Clinical Endocrinology and Metabolism, 28, 34-40.
19. Vagnucci A. and See P. (1989). Diseases of the adrenal cortex in pregnancy. In: Endocrine Disorders in Pregnancy, edited by Brody, S.A. and Ueland, K., pp. 186-187. East Norwalk, Conn., Appleton & Lange.
20. Williams R.L., Creasy R.K., Cunningham G.C., Hawes W.E., Nomis F.D. and Toshiro M. (1982). Fetal growth and perinatal viability in California. Obstetrics and Gynecology, 59, 624-632.
21. Yang J.M. and Wang K.G. (1995). Relationship between acute fetal distress and maternal-placental-fetal circulations in severe preeclampsia. Acta Obstetricia et Gynecologica Scandinavica, 74, 419-424.
22. Zeeman G.G. and Dekker G.A. (1992). Pathogenesis of preeclampsia: a hypothesis. Clinical Obstetrics and Gynecology, 35, 317-337.